Insider Purchases: Inside the Buy
Tag: Institutional Ownership
Insiders Buy Shares of Corsair Gaming: Is Management On Deck To Deliver?
Insiders and institutions are piling into Corsair Gaming (CRSR) just as revenue, margins, and product launches accelerate. With a new CFO, a strong Q3, and a massive PC upgrade cycle on deck, this stock could respawn in a big way — if management delivers.
The CEO Loves Hershey Foods: Can HSY Shine or Is It No Milky Way?
Hershey Foods just got a major vote of confidence from its CEO and big institutions — but earnings are under pressure and cocoa costs are spiking. Is HSY a sweet buy on dips or an over-priced treat? Here’s the fun, funny, data-backed breakdown you won’t get anywhere else.
Insiders Are Buying Bath & Body Works — Will BBWI Clean Up Its Act or Is It Just Soap Opera?
Bath & Body Works stock has plunged—but insiders, institutions, and some analysts still can’t resist the scent. Is BBWI a deep-value revival story or just investor soap opera? Let’s investigate—fun included. 🧼📉📈
Sweetgreen Update: When the CEO Buys the Salad Dip
Sweetgreen (SG) just delivered a wild mix of insider buying, lowered guidance, widening losses, and surprising institutional support. With the CEO buying $1M+ of stock at the lows and valuation at historic discounts, the setup is intriguing — but still risky. Here’s the full FUNanc1al breakdown.
CEO Buys Alarm.com Stock: Time To Rush In or Panic?
Alarm.com is back on investors’ radar after a rare CEO insider buy and a tidal wave of institutional ownership. With growing SaaS revenue, real profitability, and a stock still far below its 2021 highs, ALRM may be setting up for a stealth rebound. Here’s the fun, funny, icon-filled breakdown of whether to rush in, hold steady, or panic responsibly.
CEO Buys Shares of Roper Technologies: Knows the Ropes or On the Ropes?
A massive insider buy, a $3B share repurchase program, soaring cash flow, and institutions owning nearly the entire float. Is Roper Technologies signaling deep value—or just tugging on your curiosity rope?
CEO/COB at Cigna Is Buying CI. Is He Signaling: Time To Buy?
Cigna’s CEO is buying big — and Wall Street is paying attention. With earnings up, a pharmacy-benefit shake-up underway, and valuations looking healthy, CI might just be the quiet value stock investors have been waiting for. Let’s break it down — and have fun doing it. 😎💊📈
Two Directors Bought Shares of Everest Group (EG) Cheaper Than the CEO Did 6 Months Ago: Will Buying Now Culminate in Profits?
Two Everest Group directors just bought stock around $306–$307—below the CEO’s June buy—while the company cleans house with a $1.2B adverse development cover and a renewal-rights sale to AIG. Institutions own essentially all the float, short interest is low, and forward P/E looks cheap. Here’s the risk/reward.
Investor & Insider James Breyer Just Bought Blackstone (BX). Should You Sip the Alt-Assets Kool-Aid—or Sit It Out?
Blackstone remains the alt-assets apex predator: $1.24T AUM, rising perpetual capital, and a fresh insider buy from director James Breyer. We unpack fundraising momentum, distributable earnings, variable dividends, key risks (rates, exits), and why dips may be gifts for long-term investors.
CEO Bought Shares of Booz Allen Hamilton: Time to Indulge
Booz Allen just flashed insider conviction: CEO Horacio Rozanski purchased ~$2M of BAH stock. Despite near-term revenue pressure from funding delays, the firm sports a record backlog, mission-critical AI/cyber programs, and steady capital returns. We unpack the bull/bear, valuation, and what could flip the narrative from pause to play.